The multicentre randomised REGENT trial has failed to demonstrate a benefit with CD34+CXCR+ cells

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1655, 2008-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lansoprazole and Esomeprazole in Symptomatic GERD: A Double-Blind, Randomised, Multicentre Trial in 3000 Patients Confirms Comparable Symptom Relief

By Chey W.

Clinical Drug Investigation, Vol. 23, Iss. 2, 2003-01 ,pp. : 69-84

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Three Regimens for Helicobacter pylori Eradication : A Multicentre, Double-Blind, Randomised Clinical Trial

By Bujanda L.

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Metoprolol Tartrate in Patients with Mild-to-Moderate Essential Hypertension: A Randomised, Double-Blind, Multicentre Trial

By Koenig W.

Clinical Drug Investigation, Vol. 21, Iss. 9, 2001-09 ,pp. : 613-619

Adis International

Access to resources Recommend Favorite

Efficacy of FPF 1070 (Cerebrolysin) in Patients with Alzheimer's Disease: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

By Shifu X. Heqin Y. Peifen Y.

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 43-53

Adis International

Access to resources Recommend Favorite

Tamoxifen in the Treatment of Hepatocellular Carcinoma: 5-Year Results of the CLIP-1 Multicentre Randomised Controlled Trial

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 1013-1019

Bentham Science Publishers

Access to resources Recommend Favorite